T
Talis Biomedical Corp
NASDAQ:TLIS
Talis Biomedical Corp
NASDAQ:TLIS
Price:
2.84
USD
Market Cap:
$5.2m
Relative Value
There is not enough data to reliably calculate the relative value of TLIS.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TLIS
Relative Value
Base Case
Not Available
Multiples Across Competitors
TLIS Competitors Multiples
Talis Biomedical Corp Competitors
Talis Biomedical Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
T
|
Talis Biomedical Corp
NASDAQ:TLIS
|
5.2m USD | 12.7 | -0.1 | 1.2 | 1.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
188.2B USD | 4.2 | 28.9 | 16.5 | 22.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
168.4B USD | 16.7 | 58.8 | 44.5 | 54.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
130B USD | 5.2 | 40 | 20.4 | 24.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112B USD | 3.2 | 24.3 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
102.5B USD | 5.1 | 35.5 | 20.9 | 28 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.9B EUR | 1.9 | 20.7 | 11.5 | 16.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.6B USD | 7.8 | 44.2 | 24.2 | 26.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.8B USD | 2.1 | 26 | 10.2 | 17.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.5B USD | 10.6 | 43 | 30.6 | 33.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.7B USD | 6.2 | 22.7 | 16 | 17.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
